Drug interactions
Bendamustine + Ponatinib
Severity: Moderate
Bendamustine and Ponatinib: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Ponatinib inhibits P-gp in vitro and could increase exposure to P-gp substrates. Both drugs also cause myelosuppression, so overlapping cytopenias may occur independently of any kinetic effect.
What this interaction means in plain words
Bendamustine and Ponatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Bendamustine belongs to Oncology; Ponatinib belongs to Oncology.
Why it happens
P-gp inhibition by ponatinib may raise bendamustine exposure, combined with additive myelosuppressive pharmacodynamics.
What to do
Monitor complete blood counts closely and reduce doses or delay treatment for significant neutropenia or thrombocytopenia.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Bendamustine and Ponatinib, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Bendamustine
Other interactions of Ponatinib
Frequently asked questions
Can I take Bendamustine with Ponatinib?
MediHelp rates the interaction as moderate. Bendamustine and Ponatinib can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Ponatinib inhibits P-gp in vitro and could increase exposure to P-gp substrates. Both drugs also cause myelosuppression, so overlapping cytopenias may occur independently of any kinetic effect.
How serious is the interaction between Bendamustine and Ponatinib?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts closely and reduce doses or delay treatment for significant neutropenia or thrombocytopenia.
What other medicines interact with Bendamustine?
MediHelp also lists interactions of Bendamustine with, for example, Axicabtagene ciloleucel, Brexucabtagene autoleucel, Chlorambucil. The full list is on the Bendamustine page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
